Barclays upgraded Corteva (CTVA) to Overweight from Equal Weight with a price target of $84, up from $75. The firm sees the company benefitting from solid acreage growth in Latin America. Corteva’s cost savings and innovation are boosting its profitability, the analyst tells investors in a research note. Barclays sees 8% adjusted EBITDA growth in the second half of 2025 for Corteva along with double-digit gains in 2026.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA: